[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$ft6JTGfX905kcJzbs7MpPLrV47r8Fwbjp_tJvwCFKBnk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":63,"rows":70},"Assaf-Harofeh Medical Center",[4],263,false,36,9,90631,8,190,[14,17,19,21,24,26,28,30],{"name":15,"count":16},"T1DM",6,{"name":18,"count":16},"Fibromyalgia",{"name":20,"count":16},"Fever",{"name":22,"count":23},"Pain",5,{"name":25,"count":23},"Diabetes",{"name":27,"count":23},"Infertility",{"name":29,"count":23},"Hyperbaric Oxygen Therapy",{"name":31,"count":23},"Anxiety",[33,38,43,48,53,58],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06067958","Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity","2025-12","Dexmedetomidine",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06473896","Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil","2026-04-30","Ketalar",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06451562","Effect of Regional Anesthesia or Intravenous Infusion of Lidocaine on Morphine Use After Scoliosis Repair Surgery","2026-06-30","Lidocaine",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT05345613","Tranexamic Acid During Colonic Endoscopic Resection Procedures","2026-09-01","Tranexamic acid",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT03919461","Colorectal Metastasis Prevention International Trial 2","2027-02-28","Propranolol and etodolac",{"nctId":59,"briefTitle":60,"date":61,"intervention":62},"NCT07231900","Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients","2027-12-01","Sodium Bicarbonate",[64,65,66,67,68,69],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[71,113,131,161,183,201,231,267,285,323,341,365,391,416,442,460,487,505,535,553,571,589,613,631,655,679,697,736,762,788,806,831,859,883,911,935,959,982,1004,1030,1063,1081,1105,1128,1151,1178,1206,1224,1242,1260,1286,1332,1366,1394,1426,1448,1473,1496,1520,1544,1568,1594,1612,1635,1660,1683,1701,1723,1745,1763,1785,1808,1826,1850,1868,1893,1917,1940,1958,1981,2005,2030,2053,2071,2096,2120],{"intervention":52,"totalTrials":72,"cells":73},2,{"EARLY_PHASE1":74,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":111},{"trials":75,"activeCount":76},[],0,{"trials":78,"activeCount":76},[],{"trials":80,"activeCount":76},[],{"trials":82,"activeCount":76},[],{"trials":84,"activeCount":110,"soonestReadout":51},[85,101],{"nctId":86,"briefTitle":87,"status":88,"phases":89,"primaryCompletion":90,"completion":91,"start":92,"enrollment":93,"conditions":94,"interventions":99},"NCT05688020","Tranexamic Acid During Upper GI Endoscopic Resection Procedures","UNKNOWN",[68],"2025-02","2026-02","2023-02-01",200,[95,96,97,98],"Gastric Polyp","Gastric Neoplasm","Duodenal Neoplasms","Esophageal Neoplasms",[52,100],"Epinephrine",{"nctId":49,"briefTitle":50,"status":102,"phases":103,"primaryCompletion":51,"completion":104,"start":105,"enrollment":93,"conditions":106,"interventions":108},"RECRUITING",[68],"2026-10-01","2022-05-01",[107],"Colon Neoplasm",[52,109],"Standard",1,{"trials":112,"activeCount":76},[],{"intervention":109,"totalTrials":110,"cells":114},{"EARLY_PHASE1":115,"PHASE1":117,"PHASE2":119,"PHASE3":121,"PHASE4":123,"NA":129},{"trials":116,"activeCount":76},[],{"trials":118,"activeCount":76},[],{"trials":120,"activeCount":76},[],{"trials":122,"activeCount":76},[],{"trials":124,"activeCount":110,"soonestReadout":51},[125],{"nctId":49,"briefTitle":50,"status":102,"phases":126,"primaryCompletion":51,"completion":104,"start":105,"enrollment":93,"conditions":127,"interventions":128},[68],[107],[52,109],{"trials":130,"activeCount":76},[],{"intervention":37,"totalTrials":72,"cells":132},{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":139,"PHASE4":149,"NA":151},{"trials":134,"activeCount":76},[],{"trials":136,"activeCount":76},[],{"trials":138,"activeCount":76},[],{"trials":140,"activeCount":110,"soonestReadout":36},[141],{"nctId":34,"briefTitle":35,"status":102,"phases":142,"primaryCompletion":36,"completion":36,"start":143,"enrollment":144,"conditions":145,"interventions":147},[67],"2023-12-11",30,[146,37],"Retinopathy of Prematurity",[37,148],"Saline",{"trials":150,"activeCount":76},[],{"trials":152,"activeCount":110,"soonestReadout":41},[153],{"nctId":39,"briefTitle":40,"status":102,"phases":154,"primaryCompletion":41,"completion":155,"start":156,"enrollment":157,"conditions":158,"interventions":160},[69],"2026-08-30","2024-04-18",90,[159],"Cholecystectomy",[42,37],{"intervention":62,"totalTrials":110,"cells":162},{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":169,"PHASE4":179,"NA":181},{"trials":164,"activeCount":76},[],{"trials":166,"activeCount":76},[],{"trials":168,"activeCount":76},[],{"trials":170,"activeCount":110,"soonestReadout":61},[171],{"nctId":59,"briefTitle":60,"status":172,"phases":173,"primaryCompletion":61,"completion":61,"start":174,"enrollment":175,"conditions":176,"interventions":178},"NOT_YET_RECRUITING",[66,67],"2025-11-10",40,[177],"Hypertension in Dialysis Patients",[62],{"trials":180,"activeCount":76},[],{"trials":182,"activeCount":76},[],{"intervention":148,"totalTrials":110,"cells":184},{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":197,"NA":199},{"trials":186,"activeCount":76},[],{"trials":188,"activeCount":76},[],{"trials":190,"activeCount":76},[],{"trials":192,"activeCount":110,"soonestReadout":36},[193],{"nctId":34,"briefTitle":35,"status":102,"phases":194,"primaryCompletion":36,"completion":36,"start":143,"enrollment":144,"conditions":195,"interventions":196},[67],[146,37],[37,148],{"trials":198,"activeCount":76},[],{"trials":200,"activeCount":76},[],{"intervention":57,"totalTrials":72,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":225,"PHASE4":227,"NA":229},{"trials":204,"activeCount":76},[],{"trials":206,"activeCount":76},[],{"trials":208,"activeCount":110,"soonestReadout":56},[209,219],{"nctId":210,"briefTitle":211,"status":88,"phases":212,"primaryCompletion":213,"completion":213,"start":214,"enrollment":215,"conditions":216,"interventions":218},"NCT03838029","Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery",[66],"2026-01","2019-11-20",210,[217],"Pancreatic Neoplasms",[57],{"nctId":54,"briefTitle":55,"status":102,"phases":220,"primaryCompletion":56,"completion":56,"start":221,"enrollment":93,"conditions":222,"interventions":224},[66],"2019-02-28",[223],"Colorectal Neoplasms",[57],{"trials":226,"activeCount":76},[],{"trials":228,"activeCount":76},[],{"trials":230,"activeCount":76},[],{"intervention":47,"totalTrials":72,"cells":232},{"EARLY_PHASE1":233,"PHASE1":235,"PHASE2":237,"PHASE3":239,"PHASE4":241,"NA":243},{"trials":234,"activeCount":76},[],{"trials":236,"activeCount":76},[],{"trials":238,"activeCount":76},[],{"trials":240,"activeCount":76},[],{"trials":242,"activeCount":76},[],{"trials":244,"activeCount":110,"soonestReadout":46},[245,253],{"nctId":44,"briefTitle":45,"status":102,"phases":246,"primaryCompletion":46,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":252},[69],"2026-09-30","2024-09-01",105,[251],"Scoliosis",[47],{"nctId":254,"briefTitle":255,"status":256,"phases":257,"primaryCompletion":258,"completion":258,"start":259,"enrollment":260,"conditions":261,"interventions":265},"NCT03210038","Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia?","COMPLETED",[69],"2019-12-01","2017-03-01",120,[262,263,264],"Hematuria","Dysuria","Recurrent Uti",[47,266],"Water",{"intervention":42,"totalTrials":110,"cells":268},{"EARLY_PHASE1":269,"PHASE1":271,"PHASE2":273,"PHASE3":275,"PHASE4":277,"NA":279},{"trials":270,"activeCount":76},[],{"trials":272,"activeCount":76},[],{"trials":274,"activeCount":76},[],{"trials":276,"activeCount":76},[],{"trials":278,"activeCount":76},[],{"trials":280,"activeCount":110,"soonestReadout":41},[281],{"nctId":39,"briefTitle":40,"status":102,"phases":282,"primaryCompletion":41,"completion":155,"start":156,"enrollment":157,"conditions":283,"interventions":284},[69],[159],[42,37],{"intervention":286,"totalTrials":72,"cells":287},"melatonin",{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":304,"PHASE4":306,"NA":321},{"trials":289,"activeCount":76},[],{"trials":291,"activeCount":76},[],{"trials":293,"activeCount":76},[294],{"nctId":295,"briefTitle":296,"status":88,"phases":297,"completion":298,"start":299,"enrollment":300,"conditions":301,"interventions":303},"NCT00544791","The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment",[66],"2010-10","2007-10",50,[302],"Mild Cognitive Impairment (MCI)",[286],{"trials":305,"activeCount":76},[],{"trials":307,"activeCount":76},[308],{"nctId":309,"briefTitle":310,"status":88,"phases":311,"primaryCompletion":312,"start":313,"enrollment":314,"conditions":315,"interventions":318},"NCT01393574","Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties",[68],"2012-06","2011-06",46,[316,317],"Attention Deficit Hyperactivity Disorder","Sleep Onset Insomnia",[319,320],"Melatonin","Methylphenidate",{"trials":322,"activeCount":76},[],{"intervention":100,"totalTrials":110,"cells":324},{"EARLY_PHASE1":325,"PHASE1":327,"PHASE2":329,"PHASE3":331,"PHASE4":333,"NA":339},{"trials":326,"activeCount":76},[],{"trials":328,"activeCount":76},[],{"trials":330,"activeCount":76},[],{"trials":332,"activeCount":76},[],{"trials":334,"activeCount":76},[335],{"nctId":86,"briefTitle":87,"status":88,"phases":336,"primaryCompletion":90,"completion":91,"start":92,"enrollment":93,"conditions":337,"interventions":338},[68],[95,96,97,98],[52,100],{"trials":340,"activeCount":76},[],{"intervention":342,"totalTrials":110,"cells":343},"Sodium hyaluronate",{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":350,"PHASE4":352,"NA":363},{"trials":345,"activeCount":76},[],{"trials":347,"activeCount":76},[],{"trials":349,"activeCount":76},[],{"trials":351,"activeCount":76},[],{"trials":353,"activeCount":76},[354],{"nctId":355,"briefTitle":356,"status":88,"phases":357,"completion":299,"start":358,"enrollment":359,"conditions":360,"interventions":362},"NCT00422643","The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator",[68],"2007-03",60,[361],"Osteoarthritis of the Knee",[342],{"trials":364,"activeCount":76},[],{"intervention":366,"totalTrials":110,"cells":367},"Ketamine",{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":389},{"trials":369,"activeCount":76},[],{"trials":371,"activeCount":76},[],{"trials":373,"activeCount":76},[],{"trials":375,"activeCount":76},[],{"trials":377,"activeCount":76},[378],{"nctId":379,"briefTitle":380,"status":88,"phases":381,"primaryCompletion":382,"completion":383,"start":384,"enrollment":359,"conditions":385,"interventions":387},"NCT01470157","A Clinical Trial of Oral Midazolam Plus Oral Ketamine for Sedation During Laceration Repair",[68],"2012-03","2012-07","2011-07",[386],"Lacertaions",[366,388],"Normal Saline",{"trials":390,"activeCount":76},[],{"intervention":392,"totalTrials":110,"cells":393},"Ganirelix Acetate, Cetrolix Acetate",{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":402,"NA":414},{"trials":395,"activeCount":76},[],{"trials":397,"activeCount":76},[],{"trials":399,"activeCount":76},[],{"trials":401,"activeCount":76},[],{"trials":403,"activeCount":76},[404],{"nctId":405,"briefTitle":406,"status":88,"phases":407,"primaryCompletion":408,"completion":408,"start":409,"enrollment":410,"conditions":411,"interventions":413},"NCT05071339","GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth",[68],"2023-03-01","2021-04-01",15,[412],"IVF",[392],{"trials":415,"activeCount":76},[],{"intervention":417,"totalTrials":110,"cells":418},"Midazolam - active comparator",{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":425,"PHASE4":427,"NA":440},{"trials":420,"activeCount":76},[],{"trials":422,"activeCount":76},[],{"trials":424,"activeCount":76},[],{"trials":426,"activeCount":76},[],{"trials":428,"activeCount":76},[429],{"nctId":430,"briefTitle":431,"status":88,"phases":432,"primaryCompletion":433,"completion":434,"start":435,"enrollment":359,"conditions":436,"interventions":438},"NCT01925898","A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.",[68],"2014-02","2014-07","2013-08",[437],"Lacerations",[417,439],"Experimental Arm: Ketamine",{"trials":441,"activeCount":76},[],{"intervention":439,"totalTrials":110,"cells":443},{"EARLY_PHASE1":444,"PHASE1":446,"PHASE2":448,"PHASE3":450,"PHASE4":452,"NA":458},{"trials":445,"activeCount":76},[],{"trials":447,"activeCount":76},[],{"trials":449,"activeCount":76},[],{"trials":451,"activeCount":76},[],{"trials":453,"activeCount":76},[454],{"nctId":430,"briefTitle":431,"status":88,"phases":455,"primaryCompletion":433,"completion":434,"start":435,"enrollment":359,"conditions":456,"interventions":457},[68],[437],[417,439],{"trials":459,"activeCount":76},[],{"intervention":461,"totalTrials":110,"cells":462},"Montelukast",{"EARLY_PHASE1":463,"PHASE1":465,"PHASE2":467,"PHASE3":469,"PHASE4":471,"NA":485},{"trials":464,"activeCount":76},[],{"trials":466,"activeCount":76},[],{"trials":468,"activeCount":76},[],{"trials":470,"activeCount":76},[],{"trials":472,"activeCount":76},[473],{"nctId":474,"briefTitle":475,"status":88,"phases":476,"primaryCompletion":477,"completion":478,"start":479,"enrollment":157,"conditions":480,"interventions":483},"NCT05651750","Medical vs Surgical Treatment in OSA Among Children",[68],"2023-05-31","2023-06-30","2022-11-15",[481,482],"To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy","To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results",[461,484],"Fluticasone Furoate",{"trials":486,"activeCount":76},[],{"intervention":484,"totalTrials":110,"cells":488},{"EARLY_PHASE1":489,"PHASE1":491,"PHASE2":493,"PHASE3":495,"PHASE4":497,"NA":503},{"trials":490,"activeCount":76},[],{"trials":492,"activeCount":76},[],{"trials":494,"activeCount":76},[],{"trials":496,"activeCount":76},[],{"trials":498,"activeCount":76},[499],{"nctId":474,"briefTitle":475,"status":88,"phases":500,"primaryCompletion":477,"completion":478,"start":479,"enrollment":157,"conditions":501,"interventions":502},[68],[481,482],[461,484],{"trials":504,"activeCount":76},[],{"intervention":506,"totalTrials":110,"cells":507},"Synarel, 0.2 Mg\u002FInh Nasal Spray",{"EARLY_PHASE1":508,"PHASE1":510,"PHASE2":512,"PHASE3":514,"PHASE4":516,"NA":533},{"trials":509,"activeCount":76},[],{"trials":511,"activeCount":76},[],{"trials":513,"activeCount":76},[],{"trials":515,"activeCount":76},[],{"trials":517,"activeCount":76},[518],{"nctId":519,"briefTitle":520,"status":88,"phases":521,"primaryCompletion":522,"completion":522,"start":523,"enrollment":524,"conditions":525,"interventions":529},"NCT04797338","Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders",[68],"2021-09-30","2017-12-29",100,[526,527,528],"Pregnancy Early","Miscarriage","Ovarian Hyperstimulation Syndrome",[506,530,531,532],"Estrofem","Utrogestan","Hydroxyprogesterone Caproate",{"trials":534,"activeCount":76},[],{"intervention":530,"totalTrials":110,"cells":536},{"EARLY_PHASE1":537,"PHASE1":539,"PHASE2":541,"PHASE3":543,"PHASE4":545,"NA":551},{"trials":538,"activeCount":76},[],{"trials":540,"activeCount":76},[],{"trials":542,"activeCount":76},[],{"trials":544,"activeCount":76},[],{"trials":546,"activeCount":76},[547],{"nctId":519,"briefTitle":520,"status":88,"phases":548,"primaryCompletion":522,"completion":522,"start":523,"enrollment":524,"conditions":549,"interventions":550},[68],[526,527,528],[506,530,531,532],{"trials":552,"activeCount":76},[],{"intervention":531,"totalTrials":110,"cells":554},{"EARLY_PHASE1":555,"PHASE1":557,"PHASE2":559,"PHASE3":561,"PHASE4":563,"NA":569},{"trials":556,"activeCount":76},[],{"trials":558,"activeCount":76},[],{"trials":560,"activeCount":76},[],{"trials":562,"activeCount":76},[],{"trials":564,"activeCount":76},[565],{"nctId":519,"briefTitle":520,"status":88,"phases":566,"primaryCompletion":522,"completion":522,"start":523,"enrollment":524,"conditions":567,"interventions":568},[68],[526,527,528],[506,530,531,532],{"trials":570,"activeCount":76},[],{"intervention":532,"totalTrials":110,"cells":572},{"EARLY_PHASE1":573,"PHASE1":575,"PHASE2":577,"PHASE3":579,"PHASE4":581,"NA":587},{"trials":574,"activeCount":76},[],{"trials":576,"activeCount":76},[],{"trials":578,"activeCount":76},[],{"trials":580,"activeCount":76},[],{"trials":582,"activeCount":76},[583],{"nctId":519,"briefTitle":520,"status":88,"phases":584,"primaryCompletion":522,"completion":522,"start":523,"enrollment":524,"conditions":585,"interventions":586},[68],[526,527,528],[506,530,531,532],{"trials":588,"activeCount":76},[],{"intervention":590,"totalTrials":110,"cells":591},"Ibuprofen suppository",{"EARLY_PHASE1":592,"PHASE1":594,"PHASE2":596,"PHASE3":598,"PHASE4":600,"NA":611},{"trials":593,"activeCount":76},[],{"trials":595,"activeCount":76},[],{"trials":597,"activeCount":76},[],{"trials":599,"activeCount":76},[],{"trials":601,"activeCount":76},[602],{"nctId":603,"briefTitle":604,"status":88,"phases":605,"primaryCompletion":606,"completion":313,"start":607,"enrollment":175,"conditions":608,"interventions":609},"NCT00729976","Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.",[68],"2010-12","2008-09",[20],[590,610],"Ibuprofen Suspension",{"trials":612,"activeCount":76},[],{"intervention":610,"totalTrials":110,"cells":614},{"EARLY_PHASE1":615,"PHASE1":617,"PHASE2":619,"PHASE3":621,"PHASE4":623,"NA":629},{"trials":616,"activeCount":76},[],{"trials":618,"activeCount":76},[],{"trials":620,"activeCount":76},[],{"trials":622,"activeCount":76},[],{"trials":624,"activeCount":76},[625],{"nctId":603,"briefTitle":604,"status":88,"phases":626,"primaryCompletion":606,"completion":313,"start":607,"enrollment":175,"conditions":627,"interventions":628},[68],[20],[590,610],{"trials":630,"activeCount":76},[],{"intervention":632,"totalTrials":110,"cells":633},"Cetrorelix Acetate, Ganerelix Acetate",{"EARLY_PHASE1":634,"PHASE1":636,"PHASE2":638,"PHASE3":640,"PHASE4":642,"NA":653},{"trials":635,"activeCount":76},[],{"trials":637,"activeCount":76},[],{"trials":639,"activeCount":76},[],{"trials":641,"activeCount":76},[],{"trials":643,"activeCount":76},[644],{"nctId":645,"briefTitle":646,"status":88,"phases":647,"primaryCompletion":648,"completion":408,"start":649,"enrollment":410,"conditions":650,"interventions":652},"NCT04993924","GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst",[68],"2022-03-01","2021-05-01",[412,651],"Ovarian Cysts",[632],{"trials":654,"activeCount":76},[],{"intervention":656,"totalTrials":110,"cells":657},"Effect on small airways",{"EARLY_PHASE1":658,"PHASE1":660,"PHASE2":662,"PHASE3":664,"PHASE4":666,"NA":677},{"trials":659,"activeCount":76},[],{"trials":661,"activeCount":76},[],{"trials":663,"activeCount":76},[],{"trials":665,"activeCount":76},[],{"trials":667,"activeCount":76},[668],{"nctId":669,"briefTitle":670,"status":88,"phases":671,"completion":672,"start":672,"enrollment":144,"conditions":673,"interventions":676},"NCT00476736","The Effect of N-Acetylcystein on Quality of Life and Air Trapping During Rest and After Exercise",[68],"2007-05",[674,675],"Quality of Life","Exercise",[656],{"trials":678,"activeCount":76},[],{"intervention":320,"totalTrials":110,"cells":680},{"EARLY_PHASE1":681,"PHASE1":683,"PHASE2":685,"PHASE3":687,"PHASE4":689,"NA":695},{"trials":682,"activeCount":76},[],{"trials":684,"activeCount":76},[],{"trials":686,"activeCount":76},[],{"trials":688,"activeCount":76},[],{"trials":690,"activeCount":76},[691],{"nctId":309,"briefTitle":310,"status":88,"phases":692,"primaryCompletion":312,"start":313,"enrollment":314,"conditions":693,"interventions":694},[68],[316,317],[319,320],{"trials":696,"activeCount":76},[],{"intervention":698,"totalTrials":72,"cells":699},"Cannabis oil",{"EARLY_PHASE1":700,"PHASE1":702,"PHASE2":704,"PHASE3":706,"PHASE4":732,"NA":734},{"trials":701,"activeCount":76},[],{"trials":703,"activeCount":76},[],{"trials":705,"activeCount":76},[],{"trials":707,"activeCount":76},[708,719],{"nctId":709,"briefTitle":710,"status":256,"phases":711,"primaryCompletion":712,"completion":713,"start":714,"enrollment":715,"conditions":716,"interventions":718},"NCT05212493","The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder",[67],"2021-12-31","2023-12-31","2019-11-14",128,[717],"Autism Spectrum Disorder",[698],{"nctId":720,"briefTitle":721,"status":722,"phases":723,"primaryCompletion":724,"completion":725,"start":726,"enrollment":76,"conditions":727,"interventions":731},"NCT03664141","Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study)","WITHDRAWN",[67],"2019-08-15","2019-10-15","2018-09-15",[728,729,730],"Protein-Energy Malnutrition","Hemodialysis","Appetite Disorders",[698],{"trials":733,"activeCount":76},[],{"trials":735,"activeCount":76},[],{"intervention":737,"totalTrials":110,"cells":738},"Muntelukast",{"EARLY_PHASE1":739,"PHASE1":741,"PHASE2":743,"PHASE3":745,"PHASE4":758,"NA":760},{"trials":740,"activeCount":76},[],{"trials":742,"activeCount":76},[],{"trials":744,"activeCount":76},[],{"trials":746,"activeCount":76},[747],{"nctId":748,"briefTitle":749,"status":88,"phases":750,"primaryCompletion":751,"completion":752,"start":753,"enrollment":754,"conditions":755,"interventions":757},"NCT00551382","Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study",[67],"2009-12","2010-06","2007-11",500,[756],"Upper Respiratory Tract Infection",[737],{"trials":759,"activeCount":76},[],{"trials":761,"activeCount":76},[],{"intervention":763,"totalTrials":110,"cells":764},"Aspirin (200mg) and\u002For Plavix (150mg) dosage according to TEG",{"EARLY_PHASE1":765,"PHASE1":767,"PHASE2":769,"PHASE3":771,"PHASE4":784,"NA":786},{"trials":766,"activeCount":76},[],{"trials":768,"activeCount":76},[],{"trials":770,"activeCount":76},[],{"trials":772,"activeCount":76},[773],{"nctId":774,"briefTitle":775,"status":88,"phases":776,"primaryCompletion":777,"completion":778,"start":779,"enrollment":300,"conditions":780,"interventions":782},"NCT00697021","Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance",[67],"2009-06","2009-10","2008-06",[781],"Acute ST SEgment Elevation Myocardial Infarction",[763,783],"Aspirin 100mg and Plavix 75mg",{"trials":785,"activeCount":76},[],{"trials":787,"activeCount":76},[],{"intervention":783,"totalTrials":110,"cells":789},{"EARLY_PHASE1":790,"PHASE1":792,"PHASE2":794,"PHASE3":796,"PHASE4":802,"NA":804},{"trials":791,"activeCount":76},[],{"trials":793,"activeCount":76},[],{"trials":795,"activeCount":76},[],{"trials":797,"activeCount":76},[798],{"nctId":774,"briefTitle":775,"status":88,"phases":799,"primaryCompletion":777,"completion":778,"start":779,"enrollment":300,"conditions":800,"interventions":801},[67],[781],[763,783],{"trials":803,"activeCount":76},[],{"trials":805,"activeCount":76},[],{"intervention":807,"totalTrials":110,"cells":808},"Piperacillin\u002FTazobactam for 7 days",{"EARLY_PHASE1":809,"PHASE1":811,"PHASE2":813,"PHASE3":815,"PHASE4":827,"NA":829},{"trials":810,"activeCount":76},[],{"trials":812,"activeCount":76},[],{"trials":814,"activeCount":76},[],{"trials":816,"activeCount":76},[817],{"nctId":818,"briefTitle":819,"status":88,"phases":820,"primaryCompletion":821,"completion":822,"start":823,"enrollment":524,"conditions":824,"interventions":826},"NCT01027832","Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT)",[66,67],"2010-09","2011-09","2009-09",[825],"Tracheobronchitis",[807],{"trials":828,"activeCount":76},[],{"trials":830,"activeCount":76},[],{"intervention":832,"totalTrials":110,"cells":833},"Pregabalin",{"EARLY_PHASE1":834,"PHASE1":836,"PHASE2":838,"PHASE3":853,"PHASE4":855,"NA":857},{"trials":835,"activeCount":76},[],{"trials":837,"activeCount":76},[],{"trials":839,"activeCount":76},[840],{"nctId":841,"briefTitle":842,"status":88,"phases":843,"primaryCompletion":844,"completion":845,"start":846,"enrollment":847,"conditions":848,"interventions":852},"NCT02024568","Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia",[66],"2015-03","2015-05","2013-12",38,[849,850,22,851],"Taxane","Drug-related Side Effects and Adverse Reactions","Breast Cancer",[832],{"trials":854,"activeCount":76},[],{"trials":856,"activeCount":76},[],{"trials":858,"activeCount":76},[],{"intervention":860,"totalTrials":110,"cells":861},"terlipressin",{"EARLY_PHASE1":862,"PHASE1":864,"PHASE2":866,"PHASE3":877,"PHASE4":879,"NA":881},{"trials":863,"activeCount":76},[],{"trials":865,"activeCount":76},[],{"trials":867,"activeCount":76},[868],{"nctId":869,"briefTitle":870,"status":88,"phases":871,"primaryCompletion":872,"completion":872,"start":873,"enrollment":144,"conditions":874,"interventions":876},"NCT00793559","Terlipressin Administration in Septic Shock Refractory to Catecholamines",[66],"2009-07","2008-11",[875],"Septic Shock",[860,860],{"trials":878,"activeCount":76},[],{"trials":880,"activeCount":76},[],{"trials":882,"activeCount":76},[],{"intervention":884,"totalTrials":110,"cells":885},"Ribociclib",{"EARLY_PHASE1":886,"PHASE1":888,"PHASE2":890,"PHASE3":905,"PHASE4":907,"NA":909},{"trials":887,"activeCount":76},[],{"trials":889,"activeCount":76},[],{"trials":891,"activeCount":76},[892],{"nctId":893,"briefTitle":894,"status":88,"phases":895,"primaryCompletion":896,"completion":897,"start":898,"enrollment":144,"conditions":899,"interventions":904},"NCT03096912","A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well\u002FDedifferentiated Liposarcoma",[66],"2019-12","2020-04","2016-07",[900,901,902,903],"Liposarcomas, Dedifferentiated","Liposarcoma - Well Differentiated","Liposarcoma; Mixed Type","Soft-Tissue Sarcoma",[884],{"trials":906,"activeCount":76},[],{"trials":908,"activeCount":76},[],{"trials":910,"activeCount":76},[],{"intervention":912,"totalTrials":110,"cells":913},"Eptifibatide",{"EARLY_PHASE1":914,"PHASE1":916,"PHASE2":918,"PHASE3":929,"PHASE4":931,"NA":933},{"trials":915,"activeCount":76},[],{"trials":917,"activeCount":76},[],{"trials":919,"activeCount":76},[920],{"nctId":921,"briefTitle":922,"status":88,"phases":923,"primaryCompletion":924,"completion":924,"start":925,"enrollment":300,"conditions":926,"interventions":928},"NCT00945308","Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients",[66],"2010-02","2009-08",[927],"Acute Myocardial Infarction",[912,912],{"trials":930,"activeCount":76},[],{"trials":932,"activeCount":76},[],{"trials":934,"activeCount":76},[],{"intervention":936,"totalTrials":110,"cells":937},"Colchicine 0.5 MG",{"EARLY_PHASE1":938,"PHASE1":940,"PHASE2":942,"PHASE3":953,"PHASE4":955,"NA":957},{"trials":939,"activeCount":76},[],{"trials":941,"activeCount":76},[],{"trials":943,"activeCount":76},[944],{"nctId":945,"briefTitle":946,"status":88,"phases":947,"primaryCompletion":948,"completion":948,"start":949,"enrollment":300,"conditions":950,"interventions":952},"NCT05677555","Colchicine and Inflammation in Hemodialysis Patients",[66],"2023-02","2022-11-01",[951],"End Stage Renal Disease on Dialysis",[936],{"trials":954,"activeCount":76},[],{"trials":956,"activeCount":76},[],{"trials":958,"activeCount":76},[],{"intervention":960,"totalTrials":110,"cells":961},"olive oil and omega 3 in a combined cream",{"EARLY_PHASE1":962,"PHASE1":964,"PHASE2":966,"PHASE3":976,"PHASE4":978,"NA":980},{"trials":963,"activeCount":76},[],{"trials":965,"activeCount":76},[],{"trials":967,"activeCount":76},[968],{"nctId":969,"briefTitle":970,"status":88,"phases":971,"completion":358,"start":972,"enrollment":144,"conditions":973,"interventions":975},"NCT00421161","Olive Oil With Omega 3 to Treat Stasis Dermatitis",[65,66],"2007-01",[974],"Dermatitis",[960],{"trials":977,"activeCount":76},[],{"trials":979,"activeCount":76},[],{"trials":981,"activeCount":76},[],{"intervention":983,"totalTrials":110,"cells":984},"Tacrolimus 0.03% ointment",{"EARLY_PHASE1":985,"PHASE1":987,"PHASE2":989,"PHASE3":998,"PHASE4":1000,"NA":1002},{"trials":986,"activeCount":76},[],{"trials":988,"activeCount":76},[],{"trials":990,"activeCount":76},[991],{"nctId":992,"briefTitle":993,"status":88,"phases":994,"conditions":995,"interventions":997},"NCT00443105","Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study",[66],[996],"Allergic Conjunctivitis",[983],{"trials":999,"activeCount":76},[],{"trials":1001,"activeCount":76},[],{"trials":1003,"activeCount":76},[],{"intervention":1005,"totalTrials":110,"cells":1006},"Alpha blocker-alfuzosin",{"EARLY_PHASE1":1007,"PHASE1":1009,"PHASE2":1011,"PHASE3":1024,"PHASE4":1026,"NA":1028},{"trials":1008,"activeCount":76},[],{"trials":1010,"activeCount":76},[],{"trials":1012,"activeCount":76},[1013],{"nctId":1014,"briefTitle":1015,"status":88,"phases":1016,"primaryCompletion":872,"start":1017,"enrollment":1018,"conditions":1019,"interventions":1023},"NCT00409227","Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy",[66],"2006-12",150,[1020,1021,1022],"Urolithiasis","Nephrolithiasis","Ureterolithiasis",[1005],{"trials":1025,"activeCount":76},[],{"trials":1027,"activeCount":76},[],{"trials":1029,"activeCount":76},[],{"intervention":1031,"totalTrials":110,"cells":1032},"Ipilimumab",{"EARLY_PHASE1":1033,"PHASE1":1035,"PHASE2":1037,"PHASE3":1057,"PHASE4":1059,"NA":1061},{"trials":1034,"activeCount":76},[],{"trials":1036,"activeCount":76},[],{"trials":1038,"activeCount":76},[1039],{"nctId":1040,"briefTitle":1041,"status":88,"phases":1042,"primaryCompletion":1043,"completion":1044,"start":1045,"enrollment":359,"conditions":1046,"interventions":1055},"NCT02982486","A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma",[66],"2020-06","2020-12","2017-12",[1047,1048,1049,1050,1051,1052,1053,1054],"Soft Tissue Sarcoma","Bone Sarcoma","Chondrosarcoma","Gastrointestinal Stromal Sarcoma","Ewing's Tumor Metastatic","Ewing's Tumor Recurrent","Osteosarcoma","Desmoplastic Small Round Cell Tumor",[1031,1056],"Nivolumab",{"trials":1058,"activeCount":76},[],{"trials":1060,"activeCount":76},[],{"trials":1062,"activeCount":76},[],{"intervention":1056,"totalTrials":110,"cells":1064},{"EARLY_PHASE1":1065,"PHASE1":1067,"PHASE2":1069,"PHASE3":1075,"PHASE4":1077,"NA":1079},{"trials":1066,"activeCount":76},[],{"trials":1068,"activeCount":76},[],{"trials":1070,"activeCount":76},[1071],{"nctId":1040,"briefTitle":1041,"status":88,"phases":1072,"primaryCompletion":1043,"completion":1044,"start":1045,"enrollment":359,"conditions":1073,"interventions":1074},[66],[1047,1048,1049,1050,1051,1052,1053,1054],[1031,1056],{"trials":1076,"activeCount":76},[],{"trials":1078,"activeCount":76},[],{"trials":1080,"activeCount":76},[],{"intervention":1082,"totalTrials":110,"cells":1083},"Weight reduction",{"EARLY_PHASE1":1084,"PHASE1":1086,"PHASE2":1097,"PHASE3":1099,"PHASE4":1101,"NA":1103},{"trials":1085,"activeCount":76},[],{"trials":1087,"activeCount":76},[1088],{"nctId":1089,"briefTitle":1090,"status":88,"phases":1091,"primaryCompletion":845,"completion":1092,"start":1093,"enrollment":175,"conditions":1094,"interventions":1096},"NCT01950858","Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee",[65],"2015-08","2012-05",[1095],"Spontaneous Osteonecrosis of the Knee",[1082],{"trials":1098,"activeCount":76},[],{"trials":1100,"activeCount":76},[],{"trials":1102,"activeCount":76},[],{"trials":1104,"activeCount":76},[],{"intervention":1106,"totalTrials":110,"cells":1107},"Treatment with estradiol valerate",{"EARLY_PHASE1":1108,"PHASE1":1110,"PHASE2":1120,"PHASE3":1122,"PHASE4":1124,"NA":1126},{"trials":1109,"activeCount":76},[],{"trials":1111,"activeCount":76},[1112],{"nctId":1113,"briefTitle":1114,"status":88,"phases":1115,"completion":1116,"start":1117,"enrollment":260,"conditions":1118,"interventions":1119},"NCT00490308","The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment",[65],"2008-08","2007-08",[27],[1106],{"trials":1121,"activeCount":76},[],{"trials":1123,"activeCount":76},[],{"trials":1125,"activeCount":76},[],{"trials":1127,"activeCount":76},[],{"intervention":1129,"totalTrials":110,"cells":1130},"phenol",{"EARLY_PHASE1":1131,"PHASE1":1133,"PHASE2":1143,"PHASE3":1145,"PHASE4":1147,"NA":1149},{"trials":1132,"activeCount":76},[],{"trials":1134,"activeCount":76},[1135],{"nctId":1136,"briefTitle":1137,"status":88,"phases":1138,"primaryCompletion":1139,"start":313,"enrollment":359,"conditions":1140,"interventions":1142},"NCT01468415","Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs",[65],"2013-06",[1141],"Back Pain",[1129],{"trials":1144,"activeCount":76},[],{"trials":1146,"activeCount":76},[],{"trials":1148,"activeCount":76},[],{"trials":1150,"activeCount":76},[],{"intervention":1152,"totalTrials":110,"cells":1153},"Siran",{"EARLY_PHASE1":1154,"PHASE1":1156,"PHASE2":1170,"PHASE3":1172,"PHASE4":1174,"NA":1176},{"trials":1155,"activeCount":76},[],{"trials":1157,"activeCount":76},[1158],{"nctId":1159,"briefTitle":1160,"status":88,"phases":1161,"primaryCompletion":1162,"completion":1163,"start":1164,"conditions":1165,"interventions":1168},"NCT01251029","Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia",[65],"2013-09","2014-01","2011-01",[1166,1167],"Chronic Kidney Diseases","General Anesthesia",[1169,1152],"N-acetylcysteine",{"trials":1171,"activeCount":76},[],{"trials":1173,"activeCount":76},[],{"trials":1175,"activeCount":76},[],{"trials":1177,"activeCount":76},[],{"intervention":1179,"totalTrials":110,"cells":1180},"Gabapentin",{"EARLY_PHASE1":1181,"PHASE1":1196,"PHASE2":1198,"PHASE3":1200,"PHASE4":1202,"NA":1204},{"trials":1182,"activeCount":76},[1183],{"nctId":1184,"briefTitle":1185,"status":88,"phases":1186,"primaryCompletion":90,"completion":1187,"start":1188,"enrollment":1189,"conditions":1190,"interventions":1192},"NCT06212830","Pain Relief After Corneal Collagen Cross-Linking",[64],"2025-08","2024-02",51,[1191],"Provide Evidence-based Recommendations for Clinicians to Optimize Pain Control After CXL",[1179,1193,1194,1195],"Targin","NSAID","Paracetamol",{"trials":1197,"activeCount":76},[],{"trials":1199,"activeCount":76},[],{"trials":1201,"activeCount":76},[],{"trials":1203,"activeCount":76},[],{"trials":1205,"activeCount":76},[],{"intervention":1193,"totalTrials":110,"cells":1207},{"EARLY_PHASE1":1208,"PHASE1":1214,"PHASE2":1216,"PHASE3":1218,"PHASE4":1220,"NA":1222},{"trials":1209,"activeCount":76},[1210],{"nctId":1184,"briefTitle":1185,"status":88,"phases":1211,"primaryCompletion":90,"completion":1187,"start":1188,"enrollment":1189,"conditions":1212,"interventions":1213},[64],[1191],[1179,1193,1194,1195],{"trials":1215,"activeCount":76},[],{"trials":1217,"activeCount":76},[],{"trials":1219,"activeCount":76},[],{"trials":1221,"activeCount":76},[],{"trials":1223,"activeCount":76},[],{"intervention":1194,"totalTrials":110,"cells":1225},{"EARLY_PHASE1":1226,"PHASE1":1232,"PHASE2":1234,"PHASE3":1236,"PHASE4":1238,"NA":1240},{"trials":1227,"activeCount":76},[1228],{"nctId":1184,"briefTitle":1185,"status":88,"phases":1229,"primaryCompletion":90,"completion":1187,"start":1188,"enrollment":1189,"conditions":1230,"interventions":1231},[64],[1191],[1179,1193,1194,1195],{"trials":1233,"activeCount":76},[],{"trials":1235,"activeCount":76},[],{"trials":1237,"activeCount":76},[],{"trials":1239,"activeCount":76},[],{"trials":1241,"activeCount":76},[],{"intervention":1195,"totalTrials":110,"cells":1243},{"EARLY_PHASE1":1244,"PHASE1":1250,"PHASE2":1252,"PHASE3":1254,"PHASE4":1256,"NA":1258},{"trials":1245,"activeCount":76},[1246],{"nctId":1184,"briefTitle":1185,"status":88,"phases":1247,"primaryCompletion":90,"completion":1187,"start":1188,"enrollment":1189,"conditions":1248,"interventions":1249},[64],[1191],[1179,1193,1194,1195],{"trials":1251,"activeCount":76},[],{"trials":1253,"activeCount":76},[],{"trials":1255,"activeCount":76},[],{"trials":1257,"activeCount":76},[],{"trials":1259,"activeCount":76},[],{"intervention":1261,"totalTrials":110,"cells":1262},"Fluticasone Propionate",{"EARLY_PHASE1":1263,"PHASE1":1276,"PHASE2":1278,"PHASE3":1280,"PHASE4":1282,"NA":1284},{"trials":1264,"activeCount":76},[1265],{"nctId":1266,"briefTitle":1267,"status":256,"phases":1268,"primaryCompletion":1269,"completion":1270,"start":1271,"enrollment":1272,"conditions":1273,"interventions":1275},"NCT03594565","The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series",[64],"2017-06","2018-06","2016-03",13,[15,1274],"Hypersensitivity",[1261],{"trials":1277,"activeCount":76},[],{"trials":1279,"activeCount":76},[],{"trials":1281,"activeCount":76},[],{"trials":1283,"activeCount":76},[],{"trials":1285,"activeCount":76},[],{"intervention":1287,"totalTrials":1288,"cells":1289},"HBOT",3,{"EARLY_PHASE1":1290,"PHASE1":1292,"PHASE2":1315,"PHASE3":1317,"PHASE4":1319,"NA":1321},{"trials":1291,"activeCount":76},[],{"trials":1293,"activeCount":76},[1294,1305],{"nctId":1295,"briefTitle":1296,"status":88,"phases":1297,"primaryCompletion":1298,"start":1299,"enrollment":1300,"conditions":1301,"interventions":1304},"NCT02084927","Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery",[65],"2017-01","2014-04",62,[1302,1303],"Intracranial Meningioma","Neurologic Deficits",[1287],{"nctId":1306,"briefTitle":1307,"status":88,"phases":1308,"primaryCompletion":1309,"start":1310,"enrollment":1300,"conditions":1311,"interventions":1314},"NCT02122042","Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery",[65],"2017-05","2014-05",[1312,1313],"Post Low Grade Glioma Surgery","Cognitive Deficits",[1287],{"trials":1316,"activeCount":76},[],{"trials":1318,"activeCount":76},[],{"trials":1320,"activeCount":76},[],{"trials":1322,"activeCount":76},[1323],{"nctId":1324,"briefTitle":1325,"status":256,"phases":1326,"primaryCompletion":1269,"completion":1327,"start":1328,"enrollment":144,"conditions":1329,"interventions":1331},"NCT03376269","HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma",[69],"2017-11","2014-12",[18,1330],"Chronic Pain Syndrome",[1287],{"intervention":1169,"totalTrials":1288,"cells":1333},{"EARLY_PHASE1":1334,"PHASE1":1336,"PHASE2":1342,"PHASE3":1344,"PHASE4":1346,"NA":1348},{"trials":1335,"activeCount":76},[],{"trials":1337,"activeCount":76},[1338],{"nctId":1159,"briefTitle":1160,"status":88,"phases":1339,"primaryCompletion":1162,"completion":1163,"start":1164,"conditions":1340,"interventions":1341},[65],[1166,1167],[1169,1152],{"trials":1343,"activeCount":76},[],{"trials":1345,"activeCount":76},[],{"trials":1347,"activeCount":76},[],{"trials":1349,"activeCount":76},[1350,1359],{"nctId":1351,"briefTitle":1352,"status":256,"phases":1353,"completion":1354,"start":1355,"enrollment":300,"conditions":1356,"interventions":1358},"NCT00463671","Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue Oxygenation",[69],"2005-09","2003-12",[1357],"Diabetic Foot Ulcers",[1169],{"nctId":1360,"briefTitle":1361,"status":88,"phases":1362,"conditions":1363,"interventions":1365},"NCT00507052","Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients",[69],[729,1364],"Renal Failure",[1169],{"intervention":388,"totalTrials":72,"cells":1367},{"EARLY_PHASE1":1368,"PHASE1":1370,"PHASE2":1372,"PHASE3":1374,"PHASE4":1376,"NA":1382},{"trials":1369,"activeCount":76},[],{"trials":1371,"activeCount":76},[],{"trials":1373,"activeCount":76},[],{"trials":1375,"activeCount":76},[],{"trials":1377,"activeCount":76},[1378],{"nctId":379,"briefTitle":380,"status":88,"phases":1379,"primaryCompletion":382,"completion":383,"start":384,"enrollment":359,"conditions":1380,"interventions":1381},[68],[386],[366,388],{"trials":1383,"activeCount":76},[1384],{"nctId":1385,"briefTitle":1386,"status":256,"phases":1387,"primaryCompletion":1388,"completion":1389,"start":823,"enrollment":359,"conditions":1390,"interventions":1392},"NCT01377779","Efficiency of Intercoat (Oxiplex\u002FAP Gel)in Decreasing Intrauterine Adhesions",[69],"2010-11","2011-02",[1391],"Asherman Syndrome",[1393,388],"Oxiplex\u002FAP gel",{"intervention":1395,"totalTrials":72,"cells":1396},"losartan",{"EARLY_PHASE1":1397,"PHASE1":1399,"PHASE2":1401,"PHASE3":1403,"PHASE4":1405,"NA":1407},{"trials":1398,"activeCount":76},[],{"trials":1400,"activeCount":76},[],{"trials":1402,"activeCount":76},[],{"trials":1404,"activeCount":76},[],{"trials":1406,"activeCount":76},[],{"trials":1408,"activeCount":76},[1409,1417],{"nctId":1410,"briefTitle":1411,"status":88,"phases":1412,"primaryCompletion":823,"start":607,"enrollment":144,"conditions":1413,"interventions":1415},"NCT00732966","Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?",[69],[1414],"Hypertension",[1395,1416],"valsartan",{"nctId":1418,"briefTitle":1419,"status":88,"phases":1420,"primaryCompletion":823,"start":607,"enrollment":175,"conditions":1421,"interventions":1424},"NCT00732407","Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)",[69],[1422,1423],"Diabetes Mellitus","Atherosclerosis",[1425,1395],"aliskiren",{"intervention":1427,"totalTrials":110,"cells":1428},"Basal bolus insulin regimen",{"EARLY_PHASE1":1429,"PHASE1":1431,"PHASE2":1433,"PHASE3":1435,"PHASE4":1437,"NA":1439},{"trials":1430,"activeCount":76},[],{"trials":1432,"activeCount":76},[],{"trials":1434,"activeCount":76},[],{"trials":1436,"activeCount":76},[],{"trials":1438,"activeCount":76},[],{"trials":1440,"activeCount":76},[1441],{"nctId":1442,"briefTitle":1443,"status":88,"phases":1444,"primaryCompletion":313,"completion":384,"start":1445,"enrollment":93,"conditions":1446,"interventions":1447},"NCT00813475","Effect of Diabetes Control on Outcome in Hospitalized Patients: A National Israeli Study",[69],"2009-01",[25],[1427,1427],{"intervention":1449,"totalTrials":110,"cells":1450},"with Tranexamic acid",{"EARLY_PHASE1":1451,"PHASE1":1453,"PHASE2":1455,"PHASE3":1457,"PHASE4":1459,"NA":1461},{"trials":1452,"activeCount":76},[],{"trials":1454,"activeCount":76},[],{"trials":1456,"activeCount":76},[],{"trials":1458,"activeCount":76},[],{"trials":1460,"activeCount":76},[],{"trials":1462,"activeCount":76},[1463],{"nctId":1464,"briefTitle":1465,"status":256,"phases":1466,"primaryCompletion":1467,"completion":1467,"start":1468,"enrollment":300,"conditions":1469,"interventions":1472},"NCT06088407","Tranexamic Acid Prophylaxis for Heterotopic Ossification in Elbow Fracture-Dislocation Surgery",[69],"2023-09-03","2016-02-21",[1470,1471],"Elbow Dislocation","Heterotopic Ossification",[1449],{"intervention":1474,"totalTrials":110,"cells":1475},"Oral N-Acetylcysteine 1200 mg x 2\u002Fday for 4 weeks",{"EARLY_PHASE1":1476,"PHASE1":1478,"PHASE2":1480,"PHASE3":1482,"PHASE4":1484,"NA":1486},{"trials":1477,"activeCount":76},[],{"trials":1479,"activeCount":76},[],{"trials":1481,"activeCount":76},[],{"trials":1483,"activeCount":76},[],{"trials":1485,"activeCount":76},[],{"trials":1487,"activeCount":76},[1488],{"nctId":1489,"briefTitle":1490,"status":88,"phases":1491,"conditions":1492,"interventions":1495},"NCT00592618","Effect of NAC on Sleep Apnea",[69],[1493,1494],"ESRD","Sleep Apnea",[1474],{"intervention":1497,"totalTrials":110,"cells":1498},"HCG",{"EARLY_PHASE1":1499,"PHASE1":1501,"PHASE2":1503,"PHASE3":1505,"PHASE4":1507,"NA":1509},{"trials":1500,"activeCount":76},[],{"trials":1502,"activeCount":76},[],{"trials":1504,"activeCount":76},[],{"trials":1506,"activeCount":76},[],{"trials":1508,"activeCount":76},[],{"trials":1510,"activeCount":76},[1511],{"nctId":1512,"briefTitle":1513,"status":88,"phases":1514,"primaryCompletion":1515,"completion":1328,"start":435,"enrollment":524,"conditions":1516,"interventions":1519},"NCT01933126","Intrauterine Injection of HCG and Implantation Rate",[69],"2014-10",[1517,1518],"Pregnancy Rate","Implantation Rate",[1497],{"intervention":1521,"totalTrials":110,"cells":1522},"Baby D3 drops",{"EARLY_PHASE1":1523,"PHASE1":1525,"PHASE2":1527,"PHASE3":1529,"PHASE4":1531,"NA":1533},{"trials":1524,"activeCount":76},[],{"trials":1526,"activeCount":76},[],{"trials":1528,"activeCount":76},[],{"trials":1530,"activeCount":76},[],{"trials":1532,"activeCount":76},[],{"trials":1534,"activeCount":76},[1535],{"nctId":1536,"briefTitle":1537,"status":256,"phases":1538,"primaryCompletion":1164,"completion":1539,"start":1540,"enrollment":1541,"conditions":1542,"interventions":1543},"NCT01500005","The Effect of Vitamin D Supplementation on Arterial Stiffness in Diabetic Patients",[69],"2011-04","2010-08",74,[25],[1521],{"intervention":1545,"totalTrials":110,"cells":1546},"Saline infusion sonography for evaluation of cesarean scar",{"EARLY_PHASE1":1547,"PHASE1":1549,"PHASE2":1551,"PHASE3":1553,"PHASE4":1555,"NA":1557},{"trials":1548,"activeCount":76},[],{"trials":1550,"activeCount":76},[],{"trials":1552,"activeCount":76},[],{"trials":1554,"activeCount":76},[],{"trials":1556,"activeCount":76},[],{"trials":1558,"activeCount":76},[1559],{"nctId":1560,"briefTitle":1561,"status":88,"phases":1562,"primaryCompletion":1563,"completion":1564,"start":92,"enrollment":175,"conditions":1565,"interventions":1567},"NCT05672563","Cesarean Scar Evaluation Using Saline Infusion Sonography in Women With Previous Pregnancy in Scar",[69],"2023-08-01","2023-10-01",[1566],"Uterus; Scar",[1545],{"intervention":1569,"totalTrials":110,"cells":1570},"2% lidocaine",{"EARLY_PHASE1":1571,"PHASE1":1573,"PHASE2":1575,"PHASE3":1577,"PHASE4":1579,"NA":1581},{"trials":1572,"activeCount":76},[],{"trials":1574,"activeCount":76},[],{"trials":1576,"activeCount":76},[],{"trials":1578,"activeCount":76},[],{"trials":1580,"activeCount":76},[],{"trials":1582,"activeCount":76},[1583],{"nctId":1584,"briefTitle":1585,"status":88,"phases":1586,"primaryCompletion":1587,"completion":1588,"start":1589,"enrollment":1018,"conditions":1590,"interventions":1592},"NCT04433611","Efficacy of Uterine Lidocaine Flushing in HyFoSy",[69],"2020-10-01","2020-12-30","2020-06-17",[1591],"To Evaluate the Efficacy of Flushing the Uterine Cavity With Lidocaine Before Hysterosalpingo-Foam Sonography to Reduce Procedure-related Pain",[1569,1593],"0.9 % normal saline",{"intervention":1593,"totalTrials":110,"cells":1595},{"EARLY_PHASE1":1596,"PHASE1":1598,"PHASE2":1600,"PHASE3":1602,"PHASE4":1604,"NA":1606},{"trials":1597,"activeCount":76},[],{"trials":1599,"activeCount":76},[],{"trials":1601,"activeCount":76},[],{"trials":1603,"activeCount":76},[],{"trials":1605,"activeCount":76},[],{"trials":1607,"activeCount":76},[1608],{"nctId":1584,"briefTitle":1585,"status":88,"phases":1609,"primaryCompletion":1587,"completion":1588,"start":1589,"enrollment":1018,"conditions":1610,"interventions":1611},[69],[1591],[1569,1593],{"intervention":1613,"totalTrials":110,"cells":1614},"sperm capacitation",{"EARLY_PHASE1":1615,"PHASE1":1617,"PHASE2":1619,"PHASE3":1621,"PHASE4":1623,"NA":1625},{"trials":1616,"activeCount":76},[],{"trials":1618,"activeCount":76},[],{"trials":1620,"activeCount":76},[],{"trials":1622,"activeCount":76},[],{"trials":1624,"activeCount":76},[],{"trials":1626,"activeCount":76},[1627],{"nctId":1628,"briefTitle":1629,"status":88,"phases":1630,"primaryCompletion":1445,"completion":872,"start":1631,"enrollment":300,"conditions":1632,"interventions":1634},"NCT00731159","Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment",[],"2008-07",[1633],"Sperm Capacitation",[1613],{"intervention":1636,"totalTrials":110,"cells":1637},"Cymbalta \u002F Lyrica - Drug treatment",{"EARLY_PHASE1":1638,"PHASE1":1640,"PHASE2":1642,"PHASE3":1644,"PHASE4":1646,"NA":1648},{"trials":1639,"activeCount":76},[],{"trials":1641,"activeCount":76},[],{"trials":1643,"activeCount":76},[],{"trials":1645,"activeCount":76},[],{"trials":1647,"activeCount":76},[],{"trials":1649,"activeCount":76},[1650],{"nctId":1651,"briefTitle":1652,"status":256,"phases":1653,"primaryCompletion":1654,"completion":1654,"start":1655,"enrollment":1656,"conditions":1657,"interventions":1659},"NCT04316702","Hyperbaric Oxygen Therapy Compared to Pharmaceutical in Fibromyalgia With Emotional Trauma",[69],"2023-11-30","2020-03-01",48,[18,1658],"Emotional Trauma",[1636],{"intervention":1661,"totalTrials":110,"cells":1662},"Lidocaine Gel",{"EARLY_PHASE1":1663,"PHASE1":1665,"PHASE2":1667,"PHASE3":1669,"PHASE4":1671,"NA":1673},{"trials":1664,"activeCount":76},[],{"trials":1666,"activeCount":76},[],{"trials":1668,"activeCount":76},[],{"trials":1670,"activeCount":76},[],{"trials":1672,"activeCount":76},[],{"trials":1674,"activeCount":76},[1675],{"nctId":1676,"briefTitle":1677,"status":88,"phases":1678,"primaryCompletion":1163,"completion":1163,"start":1679,"enrollment":175,"conditions":1680,"interventions":1681},"NCT01837628","Reducing Urethral Pain During Urodynamic Test - Comparison Between Lidocaine Gel and Paraffin Oil",[69],"2013-02",[22],[1661,1682],"Paraffin Oil",{"intervention":1682,"totalTrials":110,"cells":1684},{"EARLY_PHASE1":1685,"PHASE1":1687,"PHASE2":1689,"PHASE3":1691,"PHASE4":1693,"NA":1695},{"trials":1686,"activeCount":76},[],{"trials":1688,"activeCount":76},[],{"trials":1690,"activeCount":76},[],{"trials":1692,"activeCount":76},[],{"trials":1694,"activeCount":76},[],{"trials":1696,"activeCount":76},[1697],{"nctId":1676,"briefTitle":1677,"status":88,"phases":1698,"primaryCompletion":1163,"completion":1163,"start":1679,"enrollment":175,"conditions":1699,"interventions":1700},[69],[22],[1661,1682],{"intervention":1702,"totalTrials":110,"cells":1703},"Ibuprofen",{"EARLY_PHASE1":1704,"PHASE1":1706,"PHASE2":1708,"PHASE3":1710,"PHASE4":1712,"NA":1714},{"trials":1705,"activeCount":76},[],{"trials":1707,"activeCount":76},[],{"trials":1709,"activeCount":76},[],{"trials":1711,"activeCount":76},[],{"trials":1713,"activeCount":76},[],{"trials":1715,"activeCount":76},[1716],{"nctId":1717,"briefTitle":1718,"status":88,"phases":1719,"primaryCompletion":606,"completion":313,"start":1720,"enrollment":144,"conditions":1721,"interventions":1722},"NCT01099462","Ibuprofen Concentration in Cerebro Spinal Fluid (CSF) of Infants and Children",[],"2007-06",[20],[1702],{"intervention":1724,"totalTrials":110,"cells":1725},"Ibuprofen, acetaminophen",{"EARLY_PHASE1":1726,"PHASE1":1728,"PHASE2":1730,"PHASE3":1732,"PHASE4":1734,"NA":1736},{"trials":1727,"activeCount":76},[],{"trials":1729,"activeCount":76},[],{"trials":1731,"activeCount":76},[],{"trials":1733,"activeCount":76},[],{"trials":1735,"activeCount":76},[],{"trials":1737,"activeCount":76},[1738],{"nctId":1739,"briefTitle":1740,"status":88,"phases":1741,"completion":1742,"start":1354,"enrollment":175,"conditions":1743,"interventions":1744},"NCT00389272","Adding a Second Drug for Febrile Children Treated With Acetaminophen",[69],"2008-12",[20],[1724],{"intervention":1416,"totalTrials":110,"cells":1746},{"EARLY_PHASE1":1747,"PHASE1":1749,"PHASE2":1751,"PHASE3":1753,"PHASE4":1755,"NA":1757},{"trials":1748,"activeCount":76},[],{"trials":1750,"activeCount":76},[],{"trials":1752,"activeCount":76},[],{"trials":1754,"activeCount":76},[],{"trials":1756,"activeCount":76},[],{"trials":1758,"activeCount":76},[1759],{"nctId":1410,"briefTitle":1411,"status":88,"phases":1760,"primaryCompletion":823,"start":607,"enrollment":144,"conditions":1761,"interventions":1762},[69],[1414],[1395,1416],{"intervention":1764,"totalTrials":110,"cells":1765},"Theophylline",{"EARLY_PHASE1":1766,"PHASE1":1768,"PHASE2":1770,"PHASE3":1772,"PHASE4":1774,"NA":1776},{"trials":1767,"activeCount":76},[],{"trials":1769,"activeCount":76},[],{"trials":1771,"activeCount":76},[],{"trials":1773,"activeCount":76},[],{"trials":1775,"activeCount":76},[],{"trials":1777,"activeCount":76},[1778],{"nctId":1779,"briefTitle":1780,"status":88,"phases":1781,"primaryCompletion":778,"completion":751,"start":872,"enrollment":144,"conditions":1782,"interventions":1784},"NCT00893009","The Effect on Small Airways of Addition of Theophylline as Inducer of Histone Deacilase Activity for Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Treated With Inhaled Steroids and Long Acting Beta Agonists",[69],[1783],"COPD",[1764],{"intervention":1786,"totalTrials":110,"cells":1787},"sitagliptin",{"EARLY_PHASE1":1788,"PHASE1":1790,"PHASE2":1792,"PHASE3":1794,"PHASE4":1796,"NA":1798},{"trials":1789,"activeCount":76},[],{"trials":1791,"activeCount":76},[],{"trials":1793,"activeCount":76},[],{"trials":1795,"activeCount":76},[],{"trials":1797,"activeCount":76},[],{"trials":1799,"activeCount":76},[1800],{"nctId":1801,"briefTitle":1802,"status":88,"phases":1803,"primaryCompletion":777,"completion":777,"start":779,"enrollment":359,"conditions":1804,"interventions":1806},"NCT00696982","The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation",[69],[1422,1805],"Arterial Stiffness",[1786,1807],"glibenclamide",{"intervention":1807,"totalTrials":110,"cells":1809},{"EARLY_PHASE1":1810,"PHASE1":1812,"PHASE2":1814,"PHASE3":1816,"PHASE4":1818,"NA":1820},{"trials":1811,"activeCount":76},[],{"trials":1813,"activeCount":76},[],{"trials":1815,"activeCount":76},[],{"trials":1817,"activeCount":76},[],{"trials":1819,"activeCount":76},[],{"trials":1821,"activeCount":76},[1822],{"nctId":1801,"briefTitle":1802,"status":88,"phases":1823,"primaryCompletion":777,"completion":777,"start":779,"enrollment":359,"conditions":1824,"interventions":1825},[69],[1422,1805],[1786,1807],{"intervention":1827,"totalTrials":110,"cells":1828},"Cymbalta \u002F Lyrica treatment",{"EARLY_PHASE1":1829,"PHASE1":1831,"PHASE2":1833,"PHASE3":1835,"PHASE4":1837,"NA":1839},{"trials":1830,"activeCount":76},[],{"trials":1832,"activeCount":76},[],{"trials":1834,"activeCount":76},[],{"trials":1836,"activeCount":76},[],{"trials":1838,"activeCount":76},[],{"trials":1840,"activeCount":76},[1841],{"nctId":1842,"briefTitle":1843,"status":256,"phases":1844,"primaryCompletion":1845,"completion":1845,"start":259,"enrollment":1846,"conditions":1847,"interventions":1849},"NCT03325959","Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome",[69],"2022-06-01",76,[18,1848],"Hyperbaric Oxygen",[1827],{"intervention":1393,"totalTrials":110,"cells":1851},{"EARLY_PHASE1":1852,"PHASE1":1854,"PHASE2":1856,"PHASE3":1858,"PHASE4":1860,"NA":1862},{"trials":1853,"activeCount":76},[],{"trials":1855,"activeCount":76},[],{"trials":1857,"activeCount":76},[],{"trials":1859,"activeCount":76},[],{"trials":1861,"activeCount":76},[],{"trials":1863,"activeCount":76},[1864],{"nctId":1385,"briefTitle":1386,"status":256,"phases":1865,"primaryCompletion":1388,"completion":1389,"start":823,"enrollment":359,"conditions":1866,"interventions":1867},[69],[1391],[1393,388],{"intervention":1869,"totalTrials":110,"cells":1870},"100% oxigen",{"EARLY_PHASE1":1871,"PHASE1":1873,"PHASE2":1875,"PHASE3":1877,"PHASE4":1879,"NA":1881},{"trials":1872,"activeCount":76},[],{"trials":1874,"activeCount":76},[],{"trials":1876,"activeCount":76},[],{"trials":1878,"activeCount":76},[],{"trials":1880,"activeCount":76},[],{"trials":1882,"activeCount":76},[1883],{"nctId":1884,"briefTitle":1885,"status":88,"phases":1886,"primaryCompletion":1887,"completion":1888,"start":823,"enrollment":1889,"conditions":1890,"interventions":1892},"NCT01448889","Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy",[69],"2012-09","2012-12",180,[1891],"Nephropathy",[1869],{"intervention":1894,"totalTrials":110,"cells":1895},"Glargine and insulin aspart or lispro",{"EARLY_PHASE1":1896,"PHASE1":1898,"PHASE2":1900,"PHASE3":1902,"PHASE4":1904,"NA":1906},{"trials":1897,"activeCount":76},[],{"trials":1899,"activeCount":76},[],{"trials":1901,"activeCount":76},[],{"trials":1903,"activeCount":76},[],{"trials":1905,"activeCount":76},[],{"trials":1907,"activeCount":76},[1908],{"nctId":1909,"briefTitle":1910,"status":1911,"phases":1912,"completion":1913,"start":1914,"enrollment":524,"conditions":1915,"interventions":1916},"NCT00464854","Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward","TERMINATED",[69],"2006-09","2005-07",[1422],[1894],{"intervention":1918,"totalTrials":110,"cells":1919},"DMSO cocktail",{"EARLY_PHASE1":1920,"PHASE1":1922,"PHASE2":1924,"PHASE3":1926,"PHASE4":1928,"NA":1930},{"trials":1921,"activeCount":76},[],{"trials":1923,"activeCount":76},[],{"trials":1925,"activeCount":76},[],{"trials":1927,"activeCount":76},[],{"trials":1929,"activeCount":76},[],{"trials":1931,"activeCount":76},[1932],{"nctId":1933,"briefTitle":1934,"status":88,"phases":1935,"primaryCompletion":1936,"completion":1888,"start":751,"enrollment":300,"conditions":1937,"interventions":1939},"NCT01074567","DMSO Efficacy in IC\u002FPBS Patients During and After Treatment",[69],"2011-12",[1938],"Cystitis, Interstitial",[1918],{"intervention":1425,"totalTrials":110,"cells":1941},{"EARLY_PHASE1":1942,"PHASE1":1944,"PHASE2":1946,"PHASE3":1948,"PHASE4":1950,"NA":1952},{"trials":1943,"activeCount":76},[],{"trials":1945,"activeCount":76},[],{"trials":1947,"activeCount":76},[],{"trials":1949,"activeCount":76},[],{"trials":1951,"activeCount":76},[],{"trials":1953,"activeCount":76},[1954],{"nctId":1418,"briefTitle":1419,"status":88,"phases":1955,"primaryCompletion":823,"start":607,"enrollment":175,"conditions":1956,"interventions":1957},[69],[1422,1423],[1425,1395],{"intervention":1959,"totalTrials":110,"cells":1960},"DMSO",{"EARLY_PHASE1":1961,"PHASE1":1963,"PHASE2":1965,"PHASE3":1967,"PHASE4":1969,"NA":1971},{"trials":1962,"activeCount":76},[],{"trials":1964,"activeCount":76},[],{"trials":1966,"activeCount":76},[],{"trials":1968,"activeCount":76},[],{"trials":1970,"activeCount":76},[],{"trials":1972,"activeCount":76},[1973],{"nctId":1974,"briefTitle":1975,"status":88,"phases":1976,"primaryCompletion":844,"completion":1977,"start":924,"enrollment":359,"conditions":1978,"interventions":1980},"NCT01069263","Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis",[69],"2015-07",[1979],"Interstitial Cystitis",[1959],{"intervention":1982,"totalTrials":110,"cells":1983},"Rosiglitasone",{"EARLY_PHASE1":1984,"PHASE1":1986,"PHASE2":1988,"PHASE3":1990,"PHASE4":1992,"NA":1994},{"trials":1985,"activeCount":76},[],{"trials":1987,"activeCount":76},[],{"trials":1989,"activeCount":76},[],{"trials":1991,"activeCount":76},[],{"trials":1993,"activeCount":76},[],{"trials":1995,"activeCount":76},[1996],{"nctId":1997,"briefTitle":1998,"status":88,"phases":1999,"completion":2000,"start":1117,"conditions":2001,"interventions":2004},"NCT00497666","Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study",[],"2007-12",[25,2002,2003],"Diabetic Nephropathy","Renal Protection",[1982],{"intervention":2006,"totalTrials":110,"cells":2007},"Oral N-Acetylcysteine 1200 mg x 2\u002Fday for 4 weeks.",{"EARLY_PHASE1":2008,"PHASE1":2010,"PHASE2":2012,"PHASE3":2014,"PHASE4":2016,"NA":2018},{"trials":2009,"activeCount":76},[],{"trials":2011,"activeCount":76},[],{"trials":2013,"activeCount":76},[],{"trials":2015,"activeCount":76},[],{"trials":2017,"activeCount":76},[],{"trials":2019,"activeCount":76},[2020],{"nctId":2021,"briefTitle":2022,"status":88,"phases":2023,"completion":2024,"start":2025,"enrollment":2026,"conditions":2027,"interventions":2029},"NCT00421785","Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients",[69],"2008-01","2007-02",20,[1493,2028],"Peritoneal Dialysis",[2006],{"intervention":2031,"totalTrials":110,"cells":2032},"aspirin and omeprazole",{"EARLY_PHASE1":2033,"PHASE1":2035,"PHASE2":2037,"PHASE3":2039,"PHASE4":2041,"NA":2043},{"trials":2034,"activeCount":76},[],{"trials":2036,"activeCount":76},[],{"trials":2038,"activeCount":76},[],{"trials":2040,"activeCount":76},[],{"trials":2042,"activeCount":76},[],{"trials":2044,"activeCount":76},[2045],{"nctId":2046,"briefTitle":2047,"status":256,"phases":2048,"primaryCompletion":1720,"completion":1720,"start":358,"enrollment":9,"conditions":2049,"interventions":2052},"NCT01061034","Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers",[69],[2050,2051],"Aspirin Blood Level","Proton Pump Inhiditor Treatment",[2031],{"intervention":266,"totalTrials":110,"cells":2054},{"EARLY_PHASE1":2055,"PHASE1":2057,"PHASE2":2059,"PHASE3":2061,"PHASE4":2063,"NA":2065},{"trials":2056,"activeCount":76},[],{"trials":2058,"activeCount":76},[],{"trials":2060,"activeCount":76},[],{"trials":2062,"activeCount":76},[],{"trials":2064,"activeCount":76},[],{"trials":2066,"activeCount":76},[2067],{"nctId":254,"briefTitle":255,"status":256,"phases":2068,"primaryCompletion":258,"completion":258,"start":259,"enrollment":260,"conditions":2069,"interventions":2070},[69],[262,263,264],[47,266],{"intervention":2072,"totalTrials":110,"cells":2073},"Continues peripheral block",{"EARLY_PHASE1":2074,"PHASE1":2076,"PHASE2":2078,"PHASE3":2080,"PHASE4":2082,"NA":2084},{"trials":2075,"activeCount":76},[],{"trials":2077,"activeCount":76},[],{"trials":2079,"activeCount":76},[],{"trials":2081,"activeCount":76},[],{"trials":2083,"activeCount":76},[],{"trials":2085,"activeCount":76},[2086],{"nctId":2087,"briefTitle":2088,"status":88,"phases":2089,"primaryCompletion":2090,"completion":2091,"start":2092,"enrollment":300,"conditions":2093,"interventions":2095},"NCT06382285","The Effect of a Prolonged Peripheral Nerve Block on the Level of Pain After a Knee Replacement",[69],"2025-10-30","2026-01-31","2024-10-30",[2094],"Knee Replacement Surgery",[2072],{"intervention":2097,"totalTrials":110,"cells":2098},"Levothyroxine",{"EARLY_PHASE1":2099,"PHASE1":2101,"PHASE2":2103,"PHASE3":2105,"PHASE4":2107,"NA":2109},{"trials":2100,"activeCount":76},[],{"trials":2102,"activeCount":76},[],{"trials":2104,"activeCount":76},[],{"trials":2106,"activeCount":76},[],{"trials":2108,"activeCount":76},[],{"trials":2110,"activeCount":76},[2111],{"nctId":2112,"briefTitle":2113,"status":256,"phases":2114,"completion":1354,"start":2115,"enrollment":2116,"conditions":2117,"interventions":2119},"NCT00498238","The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism",[69],"2003-07",34,[2118],"Subclinical Hypothyroidism",[2097],{"intervention":2121,"totalTrials":110,"cells":2122},"omega-3",{"EARLY_PHASE1":2123,"PHASE1":2125,"PHASE2":2127,"PHASE3":2129,"PHASE4":2131,"NA":2133},{"trials":2124,"activeCount":76},[],{"trials":2126,"activeCount":76},[],{"trials":2128,"activeCount":76},[],{"trials":2130,"activeCount":76},[],{"trials":2132,"activeCount":76},[],{"trials":2134,"activeCount":76},[2135],{"nctId":2136,"briefTitle":2137,"status":256,"phases":2138,"primaryCompletion":1742,"completion":1742,"start":2024,"enrollment":2139,"conditions":2140,"interventions":2145},"NCT00976872","Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins",[69],52,[2141,2142,2143,2144],"Inflammation","Blood Pressure","Platelet Function","Endothelial Function",[2121]]